Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-05-04 @ 12:22 PM
Study NCT ID:
NCT07423533
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-02-20
First Post:
2026-02-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD
Sponsor:
Changchun GeneScience Pharmaceutical Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Rheumatoid Arthritis | View |